ATM and non-small cell lung carcinoma: Furthermore, AZD6378 potentiates the cytotoxicity of cisplatin and gemcitabine in NSCLC cell lines in which ATM kinase signaling is intact, and potently synergizes with cisplatin to kill ATM-deficient NSCLC cells in vitro.